Berdagang MerckCo USA MRK

MerckCo carta live

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita Terkini

Frances Wang 2025 Mar 17, 16:00

Stock market today: Dow, S&P 500, Nasdaq remain steady on tariff tension

Stocks Indices
Frances Wang 2025 Mar 16, 16:00

Stock market index update: Hang Seng Index rises over 1.11%

Indices
Frances Wang 2025 Mar 16, 16:00

Oil Market Today: Oil prices surge amid rising tensions in the Red Sea

CFD Trading Oil Commodities
Tommy Yap 2025 Mar 16, 16:00

Morning Note: U.S. Retail Data, XRP Whale Activity, and Euro Gains

Morning Note USD Cryptocurrencies Forex
Tommy Yap 2025 Mar 15, 16:00

Week Ahead: BoJ, Fed, SNB, and BoE: How Will They Shape the Market?

Forex Indices
Frances Wang 2025 Mar 13, 16:00

Bank of Japan to discuss economic risks associated with the Trump trade war

Fed BoJ
Frances Wang 2025 Mar 13, 16:00

Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia

Indices
Tommy Yap 2025 Mar 13, 16:00

Morning Note: UK GDP Data, NVDA Stock Dip, & CAD Weakness Amid Oil Decline

Morning Note NVDA Forex Oil

Maklumat

Sebaran nilai

0.58

Spread (%)

0.6136 %

Leveraj

1:5

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Selasa

13:31 - 19:59

Isnin

13:31-19:59

Rabu

13:31-19:59

Khamis

13:31-19:59

Jumaat

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

238887600128

Saham Tertunggak

2526040064

Tarikh Pendapatan (Seterusnya)

2021-06-03

Hasil Div

2025-04-07

Tarikh Selepas Dividen

2025-03-17

Kadar dividen tahunan depan

3.24

Hasil dividen tahunan depan

0.0343

EPS

6.74

Ketahui lebih lanjut mengenai instrumen ini

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Trustpilot